{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:30:42Z","timestamp":1781893842457,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,9]]},"DOI":"10.7759\/cureus.77188","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:05:02Z","timestamp":1736435102000},"source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Humic\/Fulvic Acid Plus Epigallocatechin Gallate Treatment: A Retrospective Chart Review"],"prefix":"10.7759","author":[{"given":"Richard","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"The COVID tracking project. Accessed. October 11, 2023: https:\/\/covidtracking.com\/.."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2020.104137","article-title":"A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2","volume":"129","author":"Mhatre S","year":"2021","unstructured":"Mhatre S, Naik S, Patravale V. A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2. Comput Biol Med. 2021, 129:104137. 10.1016\/j.compbiomed.2020.104137","journal-title":"Comput Biol Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/foods11050694","article-title":"In vitro determination of inhibitory effects of humic substances complexing Zn and Se on SARS-CoV-2 virus replication","volume":"11","author":"Hajdrik P","year":"2022","unstructured":"Hajdrik P, P\u00e1lyi B, Kis Z, et al.. In vitro determination of inhibitory effects of humic substances complexing Zn and Se on SARS-CoV-2 virus replication. Foods. 2022, 11:694. 10.3390\/foods11050694","journal-title":"Foods"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.47587\/SA.2020.1202","article-title":"Humic substances as an environmental- friendly organic wastes potentially help as natural anti-virus to inhibit COVID-19","volume":"1","author":"Hafez M","year":"2020","unstructured":"Hafez M, Popov AI, Zelenkov VN, et al.. Humic substances as an environmental- friendly organic wastes potentially help as natural anti-virus to inhibit COVID-19. SA. 2020, 1:53-60. 10.47587\/SA.2020.1202","journal-title":"SA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1023\/b:ifla.0000039563.90066.5d","article-title":"An in vitro investigation of the anti-inflammatory properties of potassium humate","volume":"28","author":"Joon\u00e9 GK","year":"2004","unstructured":"Joon\u00e9 GK, van Rensburg CE. An in vitro investigation of the anti-inflammatory properties of potassium humate. Inflammation. 2004, 28:169-74. 10.1023\/b:ifla.0000039563.90066.5d","journal-title":"Inflammation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2006.06.020","article-title":"Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives","volume":"67","author":"Nagle DG","year":"2006","unstructured":"Nagle DG, Ferreira D, Zhou YD. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry. 2006, 67:1849-55. 10.1016\/j.phytochem.2006.06.020","journal-title":"Phytochemistry"},{"key":"ref7","unstructured":"Vitamin C. Accessed. October 30, 2024: https:\/\/ods.od.nih.gov\/factsheets\/VitaminC-HealthProfessional\/.."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2020.127639","article-title":"Dual effects of ascorbic acid on the stability of EGCG by the oxidation product dehydroascorbic acid promoting the oxidation and inhibiting the hydrolysis pathway","volume":"337","author":"Chen L","year":"2021","unstructured":"Chen L, Wang W, Zhang J, Cui H, Ni D, Jiang H. Dual effects of ascorbic acid on the stability of EGCG by the oxidation product dehydroascorbic acid promoting the oxidation and inhibiting the hydrolysis pathway. Food Chem. 2021, 337:127639. 10.1016\/j.foodchem.2020.127639","journal-title":"Food Chem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa478","article-title":"Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19","volume":"78","author":"Bhimraj A","year":"2020","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, et al.. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020, 78: e83-e102. 10.1093\/cid\/ciaa478","journal-title":"Clin Infect Dis"},{"key":"ref10","unstructured":"COVID-19 prognostic tool. Accessed. November 28, 2024: https:\/\/reference.medscape.com\/calculator\/731\/covid-19-prognostic-tool.."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237419","article-title":"Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19","volume":"15","author":"Jehi L","year":"2020","unstructured":"Jehi L, Ji X, Milinovich A, et al.. Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19. PLoS One. 2020, 15:e0237419. 10.1371\/journal.pone.0237419","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01191-8","article-title":"Individual and community-level risk for COVID-19 mortality in the United States","volume":"27","author":"Jin J","year":"2021","unstructured":"Jin J, Agarwala N, Kundu P, Harvey B, Zhang Y, Wallace E, Chatterjee N. Individual and community-level risk for COVID-19 mortality in the United States. Nat Med. 2021, 27:264-9. 10.1038\/s41591-020-01191-8","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7090534","article-title":"Role of Nrf2 and its activators in respiratory diseases","volume":"2019","author":"Liu Q","year":"2019","unstructured":"Liu Q, Gao Y, Ci X. Role of Nrf2 and its activators in respiratory diseases. Oxid Med Cell Longev. 2019, 2019:7090534. 10.1155\/2019\/7090534","journal-title":"Oxid Med Cell Longev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17088-0","article-title":"The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor","volume":"12","author":"LeBlanc EV","year":"2022","unstructured":"LeBlanc EV, Colpitts CC. The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor. Sci Rep. 2022, 12:12899. 10.1038\/s41598-022-17088-0","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195951","article-title":"Catechins: therapeutic perspectives in COVID-19-associated acute kidney injury","volume":"26","author":"Diniz LR","year":"2021","unstructured":"Diniz LR, Elshabrawy HA, Souza MT, Duarte AB, Datta S, de Sousa DP. Catechins: therapeutic perspectives in COVID-19-associated acute kidney injury. Molecules. 2021, 26:5951. 10.3390\/molecules26195951","journal-title":"Molecules"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00680-8","article-title":"Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor","volume":"11","author":"Liu J","year":"2021","unstructured":"Liu J, Bodnar BH, Meng F, et al.. Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor. Cell Biosci. 2021, 11:168. 10.1186\/s13578-021-00680-8","journal-title":"Cell Biosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101642","article-title":"Furin: a potential therapeutic target for COVID-19","volume":"23","author":"Wu C","year":"2020","unstructured":"Wu C, Zheng M, Yang Y, et al.. Furin: a potential therapeutic target for COVID-19. iScience. 2020, 23:101642. 10.1016\/j.isci.2020.101642","journal-title":"iScience"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.02.016","article-title":"EGCG, a green tea polyphenol, inhibits human coronavirus replication in\u00a0vitro","volume":"547","author":"Jang M","year":"2021","unstructured":"Jang M, Park R, Park YI, Cha YE, Yamamoto A, Lee JI, Park J. EGCG, a green tea polyphenol, inhibits human coronavirus replication in\u00a0vitro. Biochem Biophys Res Commun. 2021, 547:23-8. 10.1016\/j.bbrc.2021.02.016","journal-title":"Biochem Biophys Res Commun"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100306","article-title":"SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis","volume":"296","author":"Bayati A","year":"2021","unstructured":"Bayati A, Kumar R, Francis V, McPherson PS. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J Biol Chem. 2021, 296:100306. 10.1016\/j.jbc.2021.100306","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn128","article-title":"(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells","volume":"29","author":"Adachi S","year":"2008","unstructured":"Adachi S, Nagao T, To S, et al.. (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis. 2008, 29:1986-93. 10.1093\/carcin\/bgn128","journal-title":"Carcinogenesis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.09.009","article-title":"(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes","volume":"111","author":"Huang HC","year":"2014","unstructured":"Huang HC, Tao MH, Hung TM, Chen JC, Lin ZJ, Huang C. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antiviral Res. 2014, 111:100-11. 10.1016\/j.antiviral.2014.09.009","journal-title":"Antiviral Res"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.769088","article-title":"Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant","volume":"12","author":"Cheong Y","year":"2021","unstructured":"Cheong Y, Kim M, Ahn J, et al.. Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant. Front Immunol. 2021, 12:769088.","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145171","article-title":"Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID-19?","volume":"21","author":"Menegazzi M","year":"2020","unstructured":"Menegazzi M, Campagnari R, Bertoldi M, Crupi R, Di Paola R, Cuzzocrea S. Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID-19?. Int J Mol Sci. 2020, 21:5171. 10.3390\/ijms21145171","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2020.07.003","article-title":"Can activation of NRF2 be a strategy against COVID-19?","volume":"41","author":"Cuadrado A","year":"2020","unstructured":"Cuadrado A, Pajares M, Benito C, et al.. Can activation of NRF2 be a strategy against COVID-19?. Trends Pharmacol Sci. 2020, 41:598-610. 10.1016\/j.tips.2020.07.003","journal-title":"Trends Pharmacol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2022.100402","article-title":"Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: major interactions with host\/virus proteases","volume":"3","author":"Dinda B","year":"2023","unstructured":"Dinda B, Dinda S, Dinda M. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: major interactions with host\/virus proteases. Phytomed Plus. 2023, 3:100402. 10.1016\/j.phyplu.2022.100402","journal-title":"Phytomed Plus"},{"key":"ref26","article-title":"Potassium humate reduces inflammation and clinically improves the outcomes of patients with osteoarthritis of the knee","volume":"1","author":"Van Rensburg CE","year":"2010","unstructured":"Van Rensburg CE, Badenhorst BE, Gandy JJ, et al.. Potassium humate reduces inflammation and clinically improves the outcomes of patients with osteoarthritis of the knee. Open Conf Proc J. 2010, 1:","journal-title":"Open Conf Proc J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s705-002-8319-5","article-title":"In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid","volume":"147","author":"Lu FJ","year":"2002","unstructured":"Lu FJ, Tseng SN, Li ML, Shih SR. In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid. Arch Virol. 2002, 147:273-84. 10.1007\/s705-002-8319-5","journal-title":"Arch Virol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26133962","article-title":"Antiviral effects of green tea EGCG and its potential application against COVID-19","volume":"26","author":"Wang YQ","year":"2021","unstructured":"Wang YQ, Li QS, Zheng XQ, Lu JL, Liang YR. Antiviral effects of green tea EGCG and its potential application against COVID-19. Molecules. 2021, 26:3962. 10.3390\/molecules26133962","journal-title":"Molecules"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.12428","article-title":"Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-\u03b21 signalling","volume":"42","author":"Sriram N","year":"2015","unstructured":"Sriram N, Kalayarasan S, Manikandan R, Arumugam M, Sudhandiran G. Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-\u03b21 signalling. Clin Exp Pharmacol Physiol. 2015, 42:849-59. 10.1111\/1440-1681.12428","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6606423","article-title":"Humic acids inhibit platelet activation to reduce venous thromboembolism in mice","volume":"2022","author":"Lan HT","year":"2022","unstructured":"Lan HT, Zheng YT, Tong ZJ, Zhang C, Cong XY, Wang ZH. Humic acids inhibit platelet activation to reduce venous thromboembolism in mice. Evid Based Complement Alternat Med. 2022, 2022:6606423. 10.1155\/2022\/6606423","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(99)00104-8","article-title":"Antithrombotic activities of green tea catechins and (\u2212)-epigallocatechin gallate","volume":"96","author":"Kang WS","year":"1999","unstructured":"Kang WS, Lim IH, Yuk DY, et al.. Antithrombotic activities of green tea catechins and (\u2212)-epigallocatechin gallate. Thrombosis Research. 1999, 96:229-37. 10.1016\/S0049-3848(99)00104-8","journal-title":"Thrombosis Research"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.10058","article-title":"Medical drugs from humus matter: focus on mumie","volume":"57","author":"Schepetkin I","year":"2002","unstructured":"Schepetkin I, Khlebnikov A, Kwon BS. Medical drugs from humus matter: focus on mumie. Drug Development Research. 2002, 57:140-59. 10.1002\/ddr.10058","journal-title":"Drug Development Research"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S314666","article-title":"An overview on the potential roles of EGCG in the treatment of COVID-19 infection","volume":"15","author":"Bimonte S","year":"2021","unstructured":"Bimonte S, Forte CA, Cuomo M, Esposito G, Cascella M, Cuomo A. An overview on the potential roles of EGCG in the treatment of COVID-19 infection. Drug Des Devel Ther. 2021, 15:4447-54. 10.2147\/DDDT.S314666","journal-title":"Drug Des Devel Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tifs.2021.05.023","article-title":"Potential protective mechanisms of green tea polyphenol EGCG against COVID-19","volume":"114","author":"Zhang Z","year":"2021","unstructured":"Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang CS, Zhang J. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol. 2021, 114:11-24. 10.1016\/j.tifs.2021.05.023","journal-title":"Trends Food Sci Technol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/308203-covid-19-humicfulvic-acid-plus-epigallocatechin-gallate-treatment-a-retrospective-chart-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:05:11Z","timestamp":1736435111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/308203-covid-19-humicfulvic-acid-plus-epigallocatechin-gallate-treatment-a-retrospective-chart-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.77188","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}